Novartis AG Common Stock (NVS)

Accounts Payable

$4.26B

Quarterly · Period ending: · USD

NVS logo

NVS Accounts Payable

Latest reported$4.26B
NVS Quarterly Accounts Payable ($0.00 → $4.26B)
High-resolution chart · PNG

NVS accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
4,258,017,000
4,322,000,000
4,456,000,000
4,555,000,000
4,506,000,000
4,261,000,000
4,572,000,000
4,087,000,000
4,146,000,000
4,062,000,000
4,925,990,300
3,870,000,000
5,350,000,000
5,426,000,000
5,146,012,453
4,693,000,000
4,969,000,000
5,083,000,000
5,553,000,000
4,665,000,000
4,811,000,000
5,040,000,000
5,403,000,000
4,705,000,000
4,820,000,000
4,828,000,000
5,423,976,557
4,669,000,000
4,752,000,000
4,638,000,000
5,556,000,000
4,970,000,000
5,486,000,000
4,994,000,000
5,169,000,000
4,685,000,000
4,691,000,000
4,566,000,000
4,873,000,000
4,662,000,000
4,920,000,000
4,704,000,000
5,668,000,000
4,825,000,000
5,126,000,000
5,062,000,000
5,419,000,000
4,520,000,000
4,991,000,000
5,485,000,000
6,148,000,000
5,079,000,000
5,042,000,000
4,875,000,000
5,593,000,000
4,591,000,000
4,585,000,000
4,487,000,000
4,989,000,000
4,390,000,000
4,644,000,000
4,496,000,000
4,788,000,000
3,987,000,000
3,509,000,000
3,561,000,000
4,012,000,000
3,276,000,000
3,320,000,000
3,262,000,000
3,395,000,000
2,902,000,000
3,251,000,000
3,007,000,000
3,018,000,000
2,725,000,000
2,509,000,000
2,575,000,000
2,487,000,000
2,113,000,000
2,196,000,000
1,936,000,000
1,961,000,000
1,773,000,000
1,965,000,000
1,843,000,000
2,020,000,000
1,568,000,000
1,630,000,000
1,597,000,000
1,665,000,000
1,308,000,000
1,433,000,000
1,288,000,000
1,266,000,000
949,000,000
1,027,000,000
1,092,000,000
0
986,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.